Team:Paris/July 31
From 2008.igem.org
(Difference between revisions)
AnaJimenez (Talk | contribs) |
AnaJimenez (Talk | contribs) (→Transformation results) |
||
Line 67: | Line 67: | ||
|- | |- | ||
|align="center"|L110 | |align="center"|L110 | ||
- | |align="center"| | + | |align="center"|a lot ++ |
- | |align="center"|medium constitutive promoter <-> | + | |align="center"|medium constitutive promoter <-> gfp tripart |
|align="center"|4+7 | |align="center"|4+7 | ||
|- | |- | ||
- | |align="center"| | + | |align="center"|L111 |
+ | |align="center"|a lot ++ | ||
+ | |align="center"|weak constitutive promoter <-> ECFP | ||
+ | |align="center"|3+5 | ||
+ | |- | ||
+ | |align="center"|L112 | ||
+ | |align="center"|a lot ++ | ||
+ | |align="center"|weak constitutive promoter <-> gfp tripart | ||
+ | |align="center"|3+5 | ||
+ | |- | ||
+ | |align="center"|L113 | ||
+ | |align="center"|1 | ||
+ | |align="center"|Arac pBAD <-> ECFP | ||
+ | |align="center"|5+2.5 | ||
+ | |- | ||
+ | |align="center"|L114 | ||
+ | |align="center"|2 | ||
+ | |align="center"|Arac pBAD <-> gfp tripart | ||
+ | |align="center"|5+2.5 | ||
+ | |- | ||
+ | |align="center"|L115 | ||
+ | |align="center"|a lot ++ | ||
+ | |align="center"|pLas <-> ECFP | ||
+ | |align="center"|7+11 | ||
+ | |- | ||
+ | |align="center"|L110 | ||
+ | |align="center"|a lot ++ | ||
+ | |align="center"|pLas <-> gfp tripart | ||
+ | |align="center"|7+11 | ||
+ | |- | ||
+ | |align="center"|L117 | ||
|align="center"|C0040 | |align="center"|C0040 | ||
|align="center"|A | |align="center"|A |
Revision as of 13:56, 4 August 2008
Oligonucleotides designCreation of 3 oligonucleotides (O140, O141, O142) in order to create a particular plasmid
Transformation results
|